Literature DB >> 32297151

Lithium Toxicity from the Addition of an ACE Inhibitor with an Unexpected Type I Brugada Pattern ECG: Case Files of the Medical Toxicology Fellowship at the University of California, San Diego.

Aaron Schneir1, Clifford P Masom2.   

Abstract

Entities:  

Keywords:  Brugada syndrome; Lithium

Mesh：

Substances：

Year:  2020        PMID： 32297151      PMCID： PMC7320113          DOI： 10.1007/s13181-020-00773-9

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN： 1556-9039


× No keyword cloud information.
  54 in total

1.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

Authors:  Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2016-02

2.  Brugada syndrome in a patient treated with lithium.

Authors:  Christoph Laske; Surjo R Soekadar; Roman Laszlo; Christian Plewnia
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

3.  Brugada type 1 electrocardiographic pattern induced by severe hyponatremia.

Authors:  Paulino A Alvarez; Manuel Vázquez Blanco; Jorge Lerman
Journal:  Cardiology       Date:  2011-05-03       Impact factor: 1.869

4.  Brugada-like electrocardiography pattern induced by severe hyponatraemia.

Authors:  Ashenafi Tamene; Srinivasan Sattiraju; Kyuhyun Wang; David G Benditt
Journal:  Europace       Date:  2010-02-25       Impact factor: 5.214

5.  Combination angiotensin converting enzyme inhibitor/lithium therapy contraindicated in renal disease.

Authors:  G Simon
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

6.  Brugada-like electrocardiographic pattern induced by lamotrigine toxicity.

Authors:  William J Strimel; Amy Woodruff; Peter Cheung; Batool F Kirmani; Shoei K Stephen Huang
Journal:  Clin Neuropharmacol       Date:  2010 Sep-Oct       Impact factor: 1.592

7.  Enhancement of lithium elimination by multiple-dose sodium polystyrene sulfonate.

Authors:  J G Linakis; K M Hull; P G Lacouture; G R Lockhart; W J Lewander; T J Maher
Journal:  Acad Emerg Med       Date:  1997-03       Impact factor: 3.451

8.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

Review 9.  Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review.

Authors:  Ziv Harel; Shai Harel; Prakesh S Shah; Ron Wald; Jeffrey Perl; Chaim M Bell
Journal:  Am J Med       Date:  2013-01-12       Impact factor: 4.965

10.  Lithium absorption prevented by sodium polystyrene sulfonate in volunteers.

Authors:  C Tomaszewski; C Musso; J R Pearson; K Kulig; J A Marx
Journal:  Ann Emerg Med       Date:  1992-11       Impact factor: 5.721
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.